COMPANY PROFILE

RoosterBio

Explore full profile

Synthetic biology and regenerative medicine

Ballenger Creek, United StatesFounded 2012Biotech & Life Sciences

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About RoosterBio

RoosterBio operates in the regenerative medicine market, focusing on accelerating the commercialization of scalable regenerative cures. The company provides high-volume bioprocess media products and cell therapy manufacturing solutions, aimed at developing commercially viable biomanufacturing processes for cell-based therapies. RoosterBio serves biotech startups, pharmaceutical companies, and research institutions, helping them to fast-track the development and production of cell therapies. The business model revolves around selling bioprocess media and offering acceleration services, which include expertise and support in developing cell-based therapies. Revenue is generated through product sales and service fees.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: Ballenger Creek, United States
Employees: 59
Open positions: None listed
Dealroom signal: 73.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Tissue Engineering, Regenerative Medicine, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Mar 2024	$3.5M	$75M	Undisclosed	↗
DEBT✓Debt	Mar 2024	$3.5M	—	Undisclosed	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

RoosterBio website traffic

Latest recorded traffic for RoosterBio is 10K monthly website visits, up 29.9% over the last three months. RoosterBio's team grew 5.4% over the past year.

Latest monthly visits10K 3-month web change+29.9% 1-year team growth+5.4%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Director of MarketingFrederick, MD · Marketing & Communication · Sep 5, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
STStemmattersRegenerative medicine contract development and manufacturing services.	Guimarães, Portugal	Operational	44	$4.3M	$7.6M
BTBetalin therapeuticsBetalin's Micro Pancreas is a revolutionary regenerative micro-organ based on cell therapy. It eliminates the need for daily injections, constant blood glucose monitoring, and dietary constraints	Ramat Gan, Israel	Operational
HIHistocellA biopharmaceutical company that develops cell therapy products and novel medical devices for regenerative medicine	Derio, Spain	Operational
COCollplantRegenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing	Ness Ziona, Israel	Operational
OROrgenesisDeveloping and manufacturing cell-therapy solutions	Tel Aviv-Yafo, Israel	Operational
NBNC BiomatrixDeveloping a patented injectable technology to improve the treatment of intervertebral disc degeneration	Eindhoven, Netherlands	Operational
PRPrintivoPioneering 3D bioprinting to advance biomedical science with artificial human tissues and innovative bioink formulas	Sofia, Bulgaria	Operational
CMCayenne MedicalKnee And Shoulder Soft Tissue Reconstruction \| Knee and Shoulder Surgery Devices \| Cayenne Medical	Scottsdale, United States	Acquired